A helping HAND: therapeutic potential of MAGL inhibition against HIV-1-associated neuroinflammation
Abstract Background: Human immunodeficiency virus (HIV) affects nearly 40 million people globally, with roughly 80% of all people living with…
monoacylglycerol lipase (MAGL) inhibitors
Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis
Abstract Recent findings highlight the emerging role of the endocannabinoid system in the control of symptoms and disease progression in…